P/E ratio for Asensus Surgical (ASXC)
P/E ratio as of May 2024 (TTM): -0.7206
According to Asensus Surgical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.720588. At the end of 2022 the company had a P/E ratio of -1.09.
P/E ratio history for Asensus Surgical from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -1.09 | -72.41% |
| 2021 | -3.96 | 617.35% |
| 2020 | -0.5526 | 230.83% |
| 2019 | -0.1670 | -97.75% |
| 2018 | -7.42 | -71.59% |
| 2017 | -26.1 | 62.38% |
| 2016 | -16.1 | -70.55% |
| 2015 | -54.6 | -7.55% |
| 2014 | -59.1 | 432.4% |
| 2013 | -11.1 | 470.65% |
| 2012 | -1.95 | -94.76% |
| 2011 | -37.1 | -26.05% |
| 2010 | -50.2 | -53.64% |
| 2009 | -108 | 108.33% |
| 2008 | -52.0 | -79.13% |
| 2007 | -249 | 33.3% |
| 2006 | -187 | -52.07% |
| 2005 | -390 | 620% |
| 2004 | -54.2 | 137.27% |
| 2003 | -22.8 | 508.27% |
| 2002 | -3.75 | -103.53% |
| 2001 | 106 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Merit Medical MMSI | 44.3 | -6,242.82% | 🇺🇸 USA |
 Inari Medical
NARI | -840 | 116,443.71% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.